ozempic and other glp-1 drugs What to Make of the Coverage Cost Landscape Is GLP-1 the Same as
Description
Expand into niche indications: Tap into segments where small molecules are less competitive, such as NASH, Alzheimers disease and cardiovascular protection
Wu GJ, et al
The choice between them should be based on preference, compliance likelihood, and clinical factors rather than price
The one high-profile setback has come from neurology
Purifying long peptides is difficult, plus these GLP-1 peptide drugs have been modified to include a fatty acid side chain, and lipids themselves can be very difficult to purify, because theyre very hydrophobic, and tend to stick to the [purification] column, says Levine
But what Ive discovered is that it is not a copout
